References
1. CDC. From https://www.cdc.gov/obesity/data/adult.html. Accessed on 11 September 2018.
2. Aronne LJ et al. Obesity. 2013;21:2163-71.
3. Torgerson JS et al. Diabetes Care. 2004;27:155-61.
4. Allison DB et al. Obesity. 2012;20:330-42.
5. Smith SR et al. N Engl J Med. 2010;363:245-56.
6. Apovian CM et al. Obesity. 2013;21:935-43.
7. Pi-Sunyer X et al. N Engl J Med. 2015;373:11-22.
8. Colguitt JL et al. Cochrane Database Syst Rev. 2014;8(8):CD003641.
9. Ponce J et al. Surg Obes Relat Dis. 2015;11(6):1199-200.
10. Jirapinyo P, Thompson CC et al. Clin Gastroenterol Hepatol. 2017;15(5):619-30.
11. Sullivan S et al.Gastroenterology. 2017;152(7):1791-801.
12. Gomez V et al. Obesity. 2016;24(9):1849-53.
13. Food and Drug Administration. Summary of safety and effectiveness data (SSED) ORBERA Intragastric Balloon System. Available at https://www.accessdata.fda.gov/cdrh_docs/pdf14/P140008b.pdf. 2015:1-32.
14. Abu Dayyeh BK et al. Gastrointest Endosc. 2015;81:AB147.
15. Food and Drug Administration. Summary of safety and effectiveness data (SSED) ReShape Integrated Dual Balloon System. Available at https://www.accessdata.fda.gov/cdrh_docs/pdf14/P140012b.pdf. 2015:1-43.
16. Ponce J et al. Surg Obes Relat Dis. 2015;11:874-81.
17. Food and Drug Administration. Summary and effectiveness data (SSED): Obalon Balloon System. Available at https://www.accessdata.fda.gov/cdrh_docs/pdf16/P160001b.pdf. 2016:1-46.
18. Sullivan S et al. Gastroenterology. 2016;150:S1267.
19. Popov VB et al. Am J Gastroenterol. 2017;112:429-39.
20. Abu Dayyeh BK et al. Gastrointest Endosc. 2015;82(3):425-38.
21. Espinos JC et al. Obes Surg. 2013;23(9):1375-83.
22. Sullivan S et al. Obesity. 2017;25:294-301.
23. Miller K et al. Obesity Surg. 2017;27(2):310-22.
24. Jirapinyo P et al. Gastrointest Endosc. 2018;87(6):AB604-AB605.
25. Jirapinyo P, Thompson CC. Video GIE. 2018;3(10):296-300.
26. Campos J et al. SAGES 2013 Presentation. Baltimore, MD. 19 April 2013.
27. Kumar N et al. Gastroenterology. 2014;146(5):S571-2.
28. Kumar N et al. Surg Endosc. 2018;32(4):2159-64.
29. Abu Dayyeh BK et al. Clin Gastroenterol Hepatol. 2017;15:37-43.
30. Lopez-Nava G et al. Obes Surg. 2017;27(10):2649-55.
31. Food and Drug Administration. Summary of safety and effectiveness (SSED): AspireAssist. Available at https://www.accessdata.fda.gov/cdrh_docs/pdf15/p150024b.pdf. FDA,ed,2016:1-36.
